Reviewed profile

food and beverage brand · public preview

Mounjaro

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Is this your company?Claim Mounjaro to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Mounjaro — no cold outreach.
Report a changeLog in for full recordLast reviewed 28 Mar 2026 · public preview data

Overview

What Mounjaro covers.

Mounjaro is a prescription medication containing the active ingredient tirzepatide, developed by Eli Lilly and Company. It is indicated for the treatment of adults with type 2 diabetes mellitus to improve glycemic control. The drug functions as a dual GIP (Glucose-dependent insulinotropic polypeptide) and GLP-1 (Glucagon-like peptide-1) receptor agonist. It is administered as a once-weekly subcutaneous injection.

  • Positioned as a mainstream brand.

FAQ

Questions this page answers.

What does Mounjaro do?

Mounjaro is a food and beverage brand, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.